[Applications of artificial intelligence for imaging-driven diagnosis and treatment of bone and soft tissue tumors].

C B Jiao, L Liu, W F Liu
{"title":"[Applications of artificial intelligence for imaging-driven diagnosis and treatment of bone and soft tissue tumors].","authors":"C B Jiao, L Liu, W F Liu","doi":"10.3760/cma.j.cn112152-20231024-00215","DOIUrl":null,"url":null,"abstract":"<p><p>Bone and soft tissue tumors occur in the musculoskeletal system, and malignant bone tumors of bone and soft tissue account for 0.2% of all human malignant tumors, and if not diagnosed and treated in a timely manner, patients may be at risk of a poor prognosis. Image interpretation plays an increasingly important role in the diagnosis of bone and soft tissue tumors. Artificial intelligence (AI) can be applied in clinical treatment to integrate large amounts of multidimensional data, derive models, predict outcomes, and improve treatment decisions. Among these methods, deep learning is a widely employed technique in AI that predominantly utilizes convolutional neural networks (CNN). The network is implemented through repeated training of datasets and iterative parameter adjustments. Deep learning-based AI models have successfully been applied to various aspects of bone and soft tissue tumors, encompassing but not limiting in image segmentation, tumor detection, classification, grading and staging, chemotherapy effect evaluation, recurrence and prognosis prediction. This paper provides a comprehensive review of the principles and current state of AI in the medical image diagnosis and treatment of bone and soft tissue tumors. Additionally, it explores the present challenges and future prospects in this field.</p>","PeriodicalId":39868,"journal":{"name":"中华肿瘤杂志","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肿瘤杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112152-20231024-00215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Bone and soft tissue tumors occur in the musculoskeletal system, and malignant bone tumors of bone and soft tissue account for 0.2% of all human malignant tumors, and if not diagnosed and treated in a timely manner, patients may be at risk of a poor prognosis. Image interpretation plays an increasingly important role in the diagnosis of bone and soft tissue tumors. Artificial intelligence (AI) can be applied in clinical treatment to integrate large amounts of multidimensional data, derive models, predict outcomes, and improve treatment decisions. Among these methods, deep learning is a widely employed technique in AI that predominantly utilizes convolutional neural networks (CNN). The network is implemented through repeated training of datasets and iterative parameter adjustments. Deep learning-based AI models have successfully been applied to various aspects of bone and soft tissue tumors, encompassing but not limiting in image segmentation, tumor detection, classification, grading and staging, chemotherapy effect evaluation, recurrence and prognosis prediction. This paper provides a comprehensive review of the principles and current state of AI in the medical image diagnosis and treatment of bone and soft tissue tumors. Additionally, it explores the present challenges and future prospects in this field.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[人工智能在骨和软组织肿瘤成像诊断和治疗中的应用]。
骨与软组织肿瘤发生在肌肉骨骼系统,骨与软组织恶性骨肿瘤占人类恶性肿瘤的 0.2%,如果不及时诊断和治疗,患者可能面临预后不良的风险。图像解读在骨与软组织肿瘤的诊断中发挥着越来越重要的作用。人工智能(AI)可应用于临床治疗,以整合大量多维数据、推导模型、预测结果并改进治疗决策。在这些方法中,深度学习是人工智能中广泛使用的一种技术,它主要利用卷积神经网络(CNN)。该网络通过反复训练数据集和迭代参数调整来实现。基于深度学习的人工智能模型已成功应用于骨和软组织肿瘤的各个方面,包括但不限于图像分割、肿瘤检测、分类、分级和分期、化疗效果评估、复发和预后预测。本文全面回顾了人工智能在骨与软组织肿瘤医学影像诊断和治疗中的原理和现状。此外,它还探讨了该领域目前面临的挑战和未来前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中华肿瘤杂志
中华肿瘤杂志 Medicine-Medicine (all)
CiteScore
1.40
自引率
0.00%
发文量
10433
期刊介绍:
期刊最新文献
[International comparison and assessment of the quality of drug clinical trial implementation in China based on scientific regulatory system]. [A case of primary giant gastrointestinal stromal tumor of the liver]. [Chinese multidisciplinary expert consensus on the rational use of surufatinib in clinical practice(2024 edition)]. [Clinical predictive value of PD-1/PD-L1-induced electrocardiogram changes for cardiotoxicity]. [CT measurement of blood perfusion in hepatocellular carcinoma: from basic principle, measurement methods to clinical application].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1